Labiotech.eu

Scenic biotech lysosomal storage disorders

News and Trends 10 Mar 2022

Emerging Startups Take Aim at Lysosomal Storage Disorders

Lysosomal storage disorders such as Niemann-Pick type C have proved difficult to tackle in the biotech industry. With recent funding rounds in the bag, Scenic Biotech and Maze Therapeutics strive to treat these conditions by activating protective genes. Lysosomal storage disorders are inherited conditions caused by mutations in metabolic enzymes found inside our cells, leading […]

March 10, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 8 Mar 2022

The Top European Biotech Investments in February 2022

Companies developing lab automation, ophthalmological treatments, and novel foods received Europe’s top biotech investments in February 2022. European and Israeli biotech investments in February 2022 narrowly beat January’s performance. Life sciences companies in these regions bagged 52 private investments and initial public offerings (IPOs), worth €664M in total. Meanwhile, January’s tally was 41 deals totaling […]

March 8, 2022 - 4 minutesmins - By Jonathan Smith

In Depth 7 Mar 2022

Multiplexing Speeds up Writing and Editing DNA

While scientists can read DNA fast, editing and writing it is not that easy. Increasing the speed of editing and writing DNA sequences will be critical to ushering in new applications of genome engineering. Much of biotech is about reverse-engineering the designs that billions of years of evolution have put together. To be able to […]

March 7, 2022 - 6 minutesmins - By Sachin Rawat

News and Trends 3 Mar 2022

Europe’s Ophthalmology Scene Stays Hot for Biotech Funding

Ophthalmology-focused startups had a record year for venture capital funding in 2021. Impressive Series A rounds and collaborations hint at a continuing upward trend for the field in 2022. Biotech companies researching treatments for ophthalmological conditions experienced a splurge of venture capital (VC) funding in 2021, with the total more than trebling the haul from […]

March 3, 2022 - 5 minutesmins - By Jonathan Smith

News and Trends 1 Mar 2022

European Biotech Industry Braces as War Erupts in Ukraine

Europe has been blindsided by its biggest war in decades with Russia’s invasion of Ukraine. Amid a raging humanitarian crisis, the biotech industry is preparing for increasing economic uncertainty, cyber threats, and clinical trial disruptions. The invasion of Ukraine by Russian forces last week caused a widespread outcry from the European community. The geopolitical landscape […]

March 1, 2022 - 7 minutesmins - By Jonathan Smith

In Depth 28 Feb 2022

Biorobotics Teaches Machines to Sense and Respond to the World

Integrating biology and robotics would allow robots to feel, smell, or hear in order to react to changing environments, opening a wide range of applications. Our senses allow us to interact with our surroundings. They are also the basis for learning. In the quest to make machines more efficient, researchers are looking at one of […]

February 28, 2022 - 7 minutesmins - By Carlos de Rojas

Industrial plant sustainability bioeconomy

News and Trends 23 Feb 2022

EU Bioeconomy Fund Bags €300M to Scale up Sustainability Companies

The European Circular Bioeconomy Fund has smashed its funding target by raising €300M. The aim is to help sustainability-focused biotechs scale up and usher in a ‘bio-revolution’ in Europe. As European economies grapple with the aftershocks of the Covid-19 pandemic, policymakers have pledged to prioritize sustainability in plans such as the European Green Deal. However, […]

February 23, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 22 Feb 2022

Fast Stroke Treatments in the Works with TargED’s €39M Series A

Patients with sudden strokes and blood clotting conditions need faster and safer treatments. The Dutch company TargED Biopharmaceuticals has raised a €39M Series A round to fund the development of a fast-acting protein drug that could bridge this gap. Time is of the essence when treating acute ischemic stroke, a condition caused by a blood […]

February 22, 2022 - 5 minutesmins - By Jonathan Smith

Belgium biotech vc fund newton biocapital japan

News and Trends 18 Feb 2022

Belgian VC Fund Leads Investment Wave in Japanese Biotech

As US and European investor interest in Japanese biopharma startups spikes, the Belgian venture capital firm Newton Biocapital has launched a €150M fund to harness synergy between European and Japanese life sciences. Japan boasts a world-class technology industry in addition to a thriving life sciences scene. The nation hosts large companies including Takeda, Eisai, and […]

February 18, 2022 - 4 minutesmins - By Jonathan Smith

Best in Biotech 16 Feb 2022

Top 10 Biotech Companies in Stevenage, UK’s Hidden Life Sciences Gem

These are the top biotech companies based in Stevenage, an English town that has become a life sciences hub that competes with the likes of London, Oxford, and Cambridge. The UK’s life sciences scene is mostly centered around the golden triangle of London, Oxford, and Cambridge. Situated right in the middle of this triangle, the […]

February 16, 2022 - 6 minutesmins - By Clara Rodríguez Fernández

News and Trends 16 Feb 2022

Startup Bags €50M Series A to Smash Gene Therapy Vector Limits

After closing Spain’s largest biopharma Series A round, the company SpliceBio has set its foundations in the gene therapy field and joins the push to deliver bigger therapeutic genes into patients. SpliceBio was founded in 2012 to tinker with a type of protein called inteins, which can stick peptides together to form new proteins. The […]

February 16, 2022 - 5 minutesmins - By Jonathan Smith

News and Trends 15 Feb 2022

Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials

Despite the widespread rollout of vaccines over 2021, the Covid-19 pandemic remains a threat to healthcare systems worldwide. Numerous treatments and vaccines are hitting the late-stage pipeline, which could greatly expand the anti-Covid-19 arsenal. Two years ago, the Covid-19 pandemic swept the world and left economic disruption, healthcare crises, and widespread lockdowns in its wake. […]

February 15, 2022 - 7 minutesmins - By Jonathan Smith

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Emerging Startups Take Aim at Lysosomal Storage Disorders

The Top European Biotech Investments in February 2022

Multiplexing Speeds up Writing and Editing DNA

Europe’s Ophthalmology Scene Stays Hot for Biotech Funding

European Biotech Industry Braces as War Erupts in Ukraine

Biorobotics Teaches Machines to Sense and Respond to the World

EU Bioeconomy Fund Bags €300M to Scale up Sustainability Companies

Fast Stroke Treatments in the Works with TargED’s €39M Series A

Belgian VC Fund Leads Investment Wave in Japanese Biotech

Top 10 Biotech Companies in Stevenage, UK’s Hidden Life Sciences Gem

Startup Bags €50M Series A to Smash Gene Therapy Vector Limits

Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!